Tegaserod Production Cost Reports

The report provides a detailed analysis essential for establishing a tegaserod production plant. It encompasses all critical aspects necessary for tegaserod production, including the cost of tegaserod production, tegaserod plant cost, tegaserod production costs, and the overall tegaserod production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a tegaserod production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Tegaserod is a 5-HT4 receptor agonist that boosts gut motility and fluid secretion to relieve constipation-predominant irritable bowel syndrome. It is utilised in women under age sixty-five that shows no response to other treatments. It is approved by the FDA and taken as tablets twice daily before food. It requires special monitoring due to cardiovascular concerns. It is also used in chronic constipation, heartburn, or indigestion. It is not for men, elderly women, or those with a history of diarrhoea, bowel obstruction, or severe liver and kidney issues. Its common side effects include diarrhoea (often early on), headache, abdominal pain, nausea, and gas.

The market for tegaserod is driven by growing irritable bowel syndrome with constipation (IBS-C) among women under 65. Its utilisation in those who don't respond to other laxatives because of its action, boosting gut movement, contributes to its demand.

Its steady demand for this targeted therapy in GI clinics, where alternatives fall short, and ongoing patient needs for motility relief boost its market. The industrial tegaserod procurement is influenced by controlled US REMS channels through certified doctors and pharmacies, and premium pricing reflecting speciality status. The reliable supply from the manufacturer, despite past halts, and favourable reimbursement for eligible IBS-C cases, along with limited competition, impact its sourcing.

Raw Material for Tegaserod Production

According to the tegaserod production plant project report, the key raw materials used in the production of tegaserod include 5-methoxy-indole-3-carboxaldehyde, S-methyl-isothiosemicarbazide hydroiodide, and triethylamine.

Production Process of Tegaserod

The extensive tegaserod production cost report consists of the following major industrial production process:

1. From 5-methoxy-indole-3-carboxaldehyde: The production process of tegaserod starts by condensing 5-methoxy-indole-3-carboxaldehyde with S-methyl-isothiosemicarbazide hydroiodide. The reaction takes place in the presence of triethylamine, then removing methanol under vacuum, adding ethyl acetate to give solid 1-((5-methoxy-1H-indol-3-yl)methylene)-S-methyl-isothiosemicarbazide. This intermediate is then refluxed with equimolar n-pentylamine in methanol, after which the solvent is distilled off under reduced pressure to give tegaserod free base.

Tegaserod is a white to off-white crystalline powder that has a molecular formula of C16H23N5O and a molecular weight of 301.39 g/mol. It has a characteristic 5-methoxyindole core connected through an imine linkage to a pentyl-aminoguanidine moiety that enables selective agonism at 5-HT4 receptors to stimulate gut motility. It has a melting point of around 155 degree Celsius and exhibits low aqueous solubility but favourable solubility in ethanol and methanol. It has moderate lipophilicity with an XLogP3 value of 2.5 and a logP value of 1.8-2.2, which supports its oral absorption with bioavailability of 10-20%. It is highly plasma protein-bound (>98% to albumin) with renal excretion of metabolites, making it suitable for twice-daily 6 mg tablets administered 30 minutes apart.